MMP2 and gastric neoplasm: Others have been reported to have good potential to be prognostic biomarkers for CRC (CDKN1A, CDKN1B [62,63,64]), stomach cancer (MMP2, [65]) and esophageal cancer (EGFR, PIK3CA, [66,67]).